Avicanna Inc. has filed a preliminary non-offering preliminary prospectus for a proposed initial public offering by way of qualifying the issuance of 540,484 units upon conversion of 540,484 special warrants issued on December 13, 2018 at $8.00 per special warrant.
Avicanna has targeted CSE as the exchange on which it will likely seek a listing.
Toronto based Avicanna aims to establish itself as a leader in the global medical cannabis industry through product discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure.
Avicanna has two wholly-owned subsidiaries, My Cannabis, an Ontario corporation, and Avicanna LATAM a corporation governed by the laws of Colombia. It holds a 70% controlling equity interest in Sativa Nativa S.A.S., a 60% controlling equity interest in Santa Marta Golden Hemp S.A.S, both governed by the laws of Colombia.
Avicanna has raised over $13 million since its inception in November 2016.
photo credit: Avicanna
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Bloom Burton, Innovacorp backed Appili to go public on TSX Venture - March 26, 2019
- Renewal Funds holds 2nd close for fourth fund - March 26, 2019
- Brookfield acquires stake in TransAlta’s Alberta Hydro Assets for $750M - March 25, 2019